Abstract
A 41-year-old woman with monoclonal gammopathy of undetermined significance presented with a 1-year history of livedo racemosa that started on one arm after receiving the Pfizer BioNTech COVID-19 vaccine. Her primary care physician initially thought it was a benign reaction to the COVID-19 vaccine as her symptoms were on the same arm as the site of injection. However, the livedo racemosa subsequently became more widespread after COVID-19 infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
